PREGNANCY IN IN-SITU AND MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX: CHANCES OF CARRYING PREGNANCY TO FULL TERM, SPECIFIC FEATURES OF DIAGNOSIS AND DISEASE COURSE, AND OUTCOMES AND PROGNOSIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study the frequency of errors of a cytological method during pregnancy in suspected carcinoma of the uterine cervix in the smears and in the absence of a visible tumor and to determine the chance of carrying pregnancy to full term in the presence of in-situ (CIN3/CIS) and microinvasive carcinoma of the uterine cervix (MICUS). Subjects and methods. The study enrolled 102 pregnant women without visual signs of a tumor with high-grade squamous intraepithelial lesion (HSIL+) and cancer cells in the smears. Their study involved reexamination of ready cytology specimens and smears, expanded colposcopy, and a virological test for high-risk human papillomavirus (HPV) using chain polymerase reaction and hybrid capture 2 (HC2), as well as histological examination of biopsy and conization specimens during pregnancy and postpartum. Results. Out of 102 pregnant women, 43 (42.2%) were histologically found to have CIN1-2, koilocytosis; only 59 (57.8%) pregnant women with CIN3/CIS (n = 48) and MICUS without lymphovascular invasion (n = 11) were at risk for progression when carrying pregnancy to full term. Out of them, 58 patients decided to preserve pregnancy, 56 favorably carried it and gave birth to a full-term baby. Electrosurgical high-frequency conization was performed in 11 pregnant women in the second trimester and in all the patients 6-8 weeks after pregnancy termination. They fully recovered and had no disease progression. The patients are alive with no signs of incurability during follow-ups of 6 to 72 months. Conclusion. Cytological hyperdiagnosis of the degree of neoplasia is noted during pregnancy. Patents with CIN3/CIS and MICUS may carry pregnancy to full term with a favorable outcome in the fetus and the patient. Postpartum conization is sufficient to cure the majority of patients.

Full Text

Restricted Access

About the authors

Lyubov I. Korolenkova

N.N. Blokhin Russian Cancer Research Center, Federal Agency of Research Organizations

Email: l.korolenkova@mail.ru
MD, senior researcher of the scientific advisory 115478, Russia, Moscow, Kashirskoye shosse 24

References

  1. Давыдов М.И., Аксель Е.М., ред. Статистика злокачественных новообразований в России и странах СНГ в 2012 году. М.: Издательская группа РОНЦ; 2014. 226с
  2. Сухих Г.Т., Прилепская В.Н., ред. Профилактика рака шейки матки. Руководство для врачей. 3-е изд. М.: МЕДпресс-информ; 2012. 192с
  3. Кондриков Н.И. Патология матки: морфология, физиология, диагностика, основы терапии. М.: Практическая медицина; 2008. 334с.
  4. Роговская С.И. Практическая кольпоскопия. М.: ГЭОТАР-Медиа; 2012. 240с.
  5. McCredie M.R., Sharples K.J., Paul C., Baranyai J., Medley G., Jones R.W., Skegg D.C. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008; 9(5): 425-34.
  6. Moscicki A.B., Shiboski S., Hills N.K., Powell K.J., Jay N., Hanson E.N. et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004; 364(9446): 1678-83.
  7. Короленкова Л.И. Неоплазия шейки матки и беременность. В кн.: Роговская С.И., Липова Е.В., ред. Шейка матки, влагалище, вульва. Физиология, патология, кольпоскопия, эстетическая коррекция. М.: StatusPraesens; 2014.
  8. Короленкова Л.И., Брюзгин В.В. Тяжелые цервикальные интраэпителиальные неоплазии (CIN 2-3/ преинвазивный рак) и микрокарцинома шейки матки у беременных. Акушерство и гинекология. 2011; 5: 68-73.
  9. Wang Y., Yu Y., Xiao L., Mi X., Fu L., Luo Y. Clinical analysis of cervical screening in 2329 pregnant women. Nan Fang Yi Ke Da Xue Xue Bao. 2014; 34(9): 1355-8.
  10. Jordan J., Martin-Hirsch P., Arbyn M., Schenck U., Baldauf J.J., Da Silva D. et al. European guidelines for clinical management of abnormal cervical cytology. Part 2. Cytopathology. 2009; 20(1): 5-16.
  11. Amant F., Van Calsteren K., Halaska M.J., Beijnen J., Lagae L., Hanssens M. et al. Gynecologic cancers in pregnancy: guidelines of an International Consensus Meeting. Int. J. Gynecol. Cancer. 2009; 19(Suppl.1): S1-12.
  12. Apgar B.S., Kittendorf A.L., Bettcher C.M., Wong J., Kaufman A.J. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am. Fam. Physician. 2009; 80(2): 147-55.
  13. Selleret L., Mathevet P. Precancerous cervical lesions during pregnancy: diagnostic and treatment. J. Gynecol. Obstet. Biol. Reprod. (Paris). 2008; 37 (Suppl. 1): S131-8.
  14. Siegler E., Amit A., Lavie O., Auslender R., Mackuli L., Weissman A. Cervical intraepithelial neoplasia 2, 3 in pregnancy: time to consider loop cone excision in the first trimester of pregnancy? J. Low. Genit. Tract Dis. 2014; 18(2): 162-8.
  15. Peccatori F.A., Azim H.A. Jr., Orecchia R., Hoekstra H.J., Pavlidis N., Kesic V., Pentheroudakis G.; ESMO Guidelines Working Group. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013; Suppl. 6: vi160-70.
  16. Boutas I., Sofoudis C., Kalampokas E., Anastasopoulos C., Kalampokas T., Salakos N. Fertility preservation in women with early stage cervical cancer. Review of the literature. Eur. J. Gynaecol. Oncol. 2014; 35(4): 373-7.
  17. Origoni M., Salvatore S., Perino A., Cucinella G., Candiani M. Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art. Eur. Rev. Med. Pharmacol. Sci. 2014; 18(6): 851-60.
  18. Ульрих Е.А., Вербитская Е.А., Урманчеева А.Ф., Кутушева Г.Ф. Тактика ведения беременности при преинвазивном раке шейки матки. Фарматека.2014;4:68-70.
  19. Доброхотова Ю.Э., Венедиктова М.Г., Гришин И.И., Саранцев А.Н., Морозова К.В., Луценко Н.Н. Эффективность комплексного подхода к лечению дисплазии эпителия шейки матки умеренной и тяжелой степени на фоне инфицирования вирусом папилломы человека. Фарматека. 2015; 3: 44-47.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies